Evidence map›Paper›PMID 41148807›Full record

ReviewCells2025

Evolutionary Perspective of Nonclassical MHC Class I and Innate-like T Cells Relevance in Immune Surveillance.

Jacques Robert, Elnaz Najafi-Majd

Abstract readReview
In one paragraph

Review in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jacques RobertDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0003-4380-1476
Elnaz Najafi-MajdDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-7710-1625

Funding

A Xenopus Laevis Research Resource for ImmunologyR24AI059830 · NIAID · UNIVERSITY OF ROCHESTER · PI JACQUES Robert · 2004 to 2026
$7.7M
National Institute of Allergy and Infectious Diseases at the National Institutes of Health R24-AI059830National Science Foundation IntBIO - IOS 2316470NIAID NIH HHS R24 AI059830RACF Kesel fund AWD00005202
6 · The paper itself

Abstract

Unlike conventional T cells, which express a highly diverse repertoire of dimeric αβ T-cell receptors (TCRs) restricted by classical, polymorphic MHC class I molecules (MHC-Ia), a distinct group of T cells-collectively termed "innate-like T (iT) cells"-exhibits limited TCR diversity and depends instead on nonclassical, nonpolymorphic MHC class I molecules (MHC-Ib) for their development and function. While mounting evidence supports the role of iT cells as pivotal regulators and effectors in both innate and adaptive immune responses, many aspects of their biology remain incompletely understood. In humans, iT cells represent a significant fraction of the total T cell population, and evolutionarily conserved subsets have also been identified in other mammals and amphibians. Moreover, the expanding catalog of nonpolymorphic

Indexed as

Evolution, MolecularHistocompatibility Antigens Class IImmunity, InnateImmunologic SurveillanceT-LymphocytesAnimalsBiological EvolutionHumansHistocompatibility Antigens Class Icomparative immunologyMHC evolutionunconventional T cellsvertebrates

Identifiers

PMID41148807
PMCPMC12562908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.